Advertisement
Research Article

Nonequivalence of Classical MHC Class I Loci in Ability to Direct Effective Antiviral Immunity

  • Kevin D. Pavelko equal contributor,

    equal contributor Contributed equally to this work with: Kevin D. Pavelko, Yanice Mendez-Fernandez

    Affiliation: Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Yanice Mendez-Fernandez equal contributor,

    equal contributor Contributed equally to this work with: Kevin D. Pavelko, Yanice Mendez-Fernandez

    Affiliation: Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

    Current address: Department of Medicine, Division of Cardiovascular Medicine, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America

    X
  • Michael P. Bell,

    Affiliation: Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Michael J. Hansen,

    Affiliation: Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Aaron J. Johnson,

    Affiliations: Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America, Department of Neurology, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Chella S. David,

    Affiliation: Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Moses Rodriguez,

    Affiliations: Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America, Department of Neurology, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Larry R. Pease mail

    pease.larry@mayo.edu

    Affiliation: Department of Immunology, Mayo Clinic, Rochester, Minnesota, United States of America

    X
  • Published: February 23, 2012
  • DOI: 10.1371/journal.ppat.1002541

Viewed info

Cited info

Saved info

Discussed info

Questions or concerns about usage data? Please let us know.